Lek Takeover: What Changes Did Lek Shareholders Reject?
Ljubljana, 27 September - The key change in the statute of the Slovenian pharmaceutical company Lek sought by Novartis before carrying out its takeover bid was that of a limit on representation in the company. To protect itself from hostile takeovers, Lek had previously implemented a 15-percent limit on voting rights of shareholders. This way no shareholder, even a majority one, could dictate decision-making in the company.
The rest of this news item is available to subscribers.
The news item consists of 1.972 characters (without spaces) or 378 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.